share_log

The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product

The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product

美國食品和藥物管理局針對Mimedx的指定申請發佈了裁決書,指出Axiofill不符合人體細胞、組織或細胞或組織類產品的監管分類要求
Benzinga ·  03/27 08:09

The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product

美國食品和藥物管理局針對Mimedx的指定申請發佈了裁決書,指出Axiofill不符合人體細胞、組織或細胞或組織類產品的監管分類要求

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論